Učitavanje...

Application of Ventana immunocytochemical analysis on ThinPrep cytology slides for detection of ALK rearrangement in patients with advanced non–small-cell lung cancer

Abstract Background Ventana ALK (D5F3) screening of anaplastic lymphoma kinase (ALK) gene rearrangement in tissue specimens has been approved by US FDA (Food and Drug Administration) to select treatment for non–small-cell lung carcinoma (NSCLC). However, tumor tissues are often not readily obtainabl...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hui Qin Guo, Jia Jia, Lin Lin Zhao, Huan Zhao, Cong Wang, Yue Sun, Jian Ming Ying, Lei Guo, Jian Cao, Zhi Hui Zhang
Format: Artigo
Jezik:Inglês
Izdano: BMC 2018-12-01
Serija:BMC Cancer
Teme:
Online pristup:http://link.springer.com/article/10.1186/s12885-018-5184-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!